Ownership

Joel Lewis - President and CEO, Director at Galectin Therapeutics Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Stock Symbol: GALT on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Joel Lewis - trading volume in the past year for Galectin Therapeutics Inc

	Shares	%	Avg Price	Total $
Buys	+1K	100%	$3.39	+$3.39K
Sells
Net	+1K	100%		+$3.39K

Holdings reported by Joel Lewis for Galectin Therapeutics Inc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	897K	$3.04M	$3.39	Apr 24, 2024	Direct
Restricted Stock Unit	56K	$100K	$1.79	Jan 24, 2024	Direct	Common Stock
Common Stock	2K	$6.78K	$3.39	Apr 24, 2024	as UTMA custodian for a minor child
Stock Option (right to buy)	91K			Jan 24, 2024	Direct	Common Stock

Transactions reported by Joel Lewis for Galectin Therapeutics Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.